GlassScriptPhysician profile
Eduardo Smith Singares
NPI 1477554756
$3,359.77
in general payments reported to CMS, 2019-2025
18 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2021: $249 · 2022: $126 · 2023: $720 · 2024: $1,674 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,054 · Travel and Lodging: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,054.38 |
| Travel and Lodging | $631.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,704.52 | 2021-2025 | Advantagerib |
| Integra Lifesciences Corporation | $355.70 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $178.00 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $164.00 | 2024 | Ligasure |
| Aroa Biosurgery Incorporated | $150.98 | 2023 | |
| Prytime Medical Devices, INC. | $137.94 | 2021-2023 | Er-Reboa Plus |
| Avita Medical Americas, LLC | $121.11 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $115.69 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $93.79 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.60 | 2023-2024 | Gattex |
| Davol INC. | $62.50 | 2024 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $46.01 | 2019 | |
| Depuy Synthes Sales INC. | $34.60 | 2019 | |
| Portola Pharmaceuticals, LLC | $32.93 | 2019 | |
| Acell, INC. | $30.70 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolder Surgical LLC | $13.73 | 2019 | |
| Boston Scientific Corporation | $12.54 | 2019 | |
| Advanced Respiratory, INC | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Smith Singares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.